Crohn's disease is a condition which encompasses a wide variety of complaints and symptoms. These may be related to the inflammatory activity, but even when there is little activity there may be considerable subjective complaints-for example, of abdominal pain as a result of the presence of an inactive fibrous stricture. This diversity of the causes of the complaints and the lesions found greatly impedes exact evaluation of the effect of various types of therapeutic medication on the inflammatory activity. During the preparations for a prospective study which was to establish the effect of various types of therapeutic medication on the inflammatory activity in Crohn's disease, the need arose for an optimally objective and quantifiable standard of inflammatory activity. The Crohn's Disease Activity Index (CDAI) described by Best et al. ' has, we believe, several disadvantages. With the aid of data from a retrospective study, we therefore attempted to develop a more suitable activity index-that is, an optimally objective and reproducible quantitative *Address for correspondence: P A M van Hees, Department of Medicine, Division of Gastroenterology, St. Radboud Hospital, Nijmegen, The Netherlands.
Received for publication 25 October 1979 standard of inflammatory activity-for patients with Crohn's disease. The retrospective study covered the data on 63 patients with Crohn's disease who, during the period 1963-75, had been submitted to a total of 85 clinical examinations. Crohn's disease was diagnosed on the basis of macroscopic and histological lesions in resected specimens and/or typical features found at radiological examination of the colon and small intestine. Some data on these patients are listed in Table 1 . None of these patients was using obstipants or an elemental diet. Patients who had undergone extensive bowel resections (more than 1 m of small intestine or more than one-third of the colon) and patients with an ileostomy or colostomy were not included in the study. The study considered only those hospital periods in which the 18 variables listed in Table 2 had all been collected. The Quetelet-index albumiin 45-55 g/l, and y-globulin 6-12 g/l; haemoglobin level 8-7-10-7 mmol/l for males and 7-9-9.8 mmol/l for females.
STATISTICAL METHODS
The series of values of the variables listed in Table 2 , obtained in one examination, will be referred to as a measurement set. Of each of the 85 measurement sets, two prints were made. These prints were laid out in random order, and three specialists in the department of gastroenterology who were involved in the treatment of patients with Crohn's disease were asked, independently and without knowledge of the patient's identity, to rate the activity of the inflammation from each measurement set. The following activity score was used: 1=not active, 2=slight, 3=moderate, 4=severe, and 5=very severe inflammatory activity. Next, an effort was made to establish whether sufficient agreement existed between the two ratings of the same measurement set by each of the specialists. This agreement was found to be very good. The two activity scores per specialist were identical for 75, 78, and 81 of the 85 measurement sets, respectively. The difference between the two activity scores assigned to the same measurement set by one specialist never exceeded 1 point. In an effort to establish whether the activity scores assigned by the three specialists were in agreement, the correlation coefficients between the specialists' mean activity scores were calculated. These correlation coefficients were 0.92, 0.88, and 0.90, respectively. In view of these results it was considered justifiable to summarise the specialists' scores for each measurement set in a single figure. Each measurement set was rated twice by each specialist, and the sum of their activity scores had consequently to range from a minimum of 6 points to a maximum of 30 points. This sum, multiplied by factor 10 for convenience, was called the (physician's) activity rating (y) and regarded as a standard of the subjective view of the three specialists on the inflammatory activity of the disease. This activity rating can range from 60 to 300 points. The boundaries between the activity classes were defined as indicated in Table 3 . On the basis of this classification, disease activity was absent for 8%, slight for with respect to x1': x1l'=co+c,xl'±s (residual SD).
The coefficients with respect to x1' then are: b= -261 +-493 co/c1 and b1"=-4.93/cl.
EVALUATION OF ACTIVITY INDEX (AI) AND CDAI
The retrospective data were analysed also by three gastroenterologists from three other institutions, not involved in the development of the Al, to see if there was a correlation between their evaluation scores and the AI. The two activity scores per gastroenterologist were identical for 78, 60, and 65 of the 85 measurement sets, respectively. Except for one measurement set the difference between the two activity scores assigned to the same measurement set by one gastroenterologist never exceeded 1 point. The correlation coefficients between the gastroenterologists' mean In order to establish whether the stay in hospital influenced AI and CDAI, both indices were calculated in 16 of the 64 patients at the end of a hospital period and at the first outpatient follow-up two weeks after discharge from hospital.
In the same 16 patients, finally, the AI and CDAI were determined before and during therapeutic medication (one to six months later). An attempt was made to establish whether the change in AI and CDAI corresponded with the physician's assessment of the effect of therapy, so far as this became manifest in a change in the physician's activity score. In all cases this assessment of inflammatory activity was made before AI and CDAI were calculated.
Results

ACTIVITY INDEX (AI)
It proved to be possible to develop, on the basis of nine variables, an activity index which attained a correlation coefficient of 95% with the corresponding physician's rating (activity rating y). Table 4 lists these variables and the constants (bi) required for calculation of the AI. Figure 1 shows the relation between AI and physician's rating. It also indicates the boundaries For codes see Table 2 .
of the activity classes (no, slight, moderate, anh severe-to-very-severe inflammatory activity), botd according to the AI (5) and according to the physician's rating (y) (cf Table 3 ). To avoid patients with no or very slight activity according to the AI from being erroneously included in the slight activity class, the boundary between 'no' and 'slight' activity was set at AI= 100. An AI in the range 100-150 can be regarded as indicating slight inflammatory activity, an AI in the range 150-210 as indicating moderate, and an Al>210 as indicating severe-to-very-severe inflammatory activity. Figure 1 shows that the vast majority (780h) of the Crohn's (very) disease.
severe Figure 4 shows that only a moderate correlation (r=0.67) existed between AI and CDAI in the 64 patients; if for both indices the boundary between 210 no or slight activity and moderate or severe activity modeiate is set at 150, then 34% of the patients are not moderate identically classified according to both criteria.
The correlation between AI and physician's rating 150 was also studied for some special groups in the series slight of 64 patients. In all these groups the correlation coefficient between AI and physician's rating was 100 high: r=0 91 for 36 patients with Crohn's disease localised in the small intestine; r=0.92 for 25 patients with localisations in both the small intestine no and the colon; r=0.86 for 22 patients who had undergone resection, and r=0.91 for 42 patients without resection. Figure 5 indicates the AI and CDAI in 16 patients during the hospital period and at an outpatient follow-up 14 days later. In view of the short interval e between the two observations the disease activity 85 measurement sets are included in the same activity class by AI as by physician's rating.
EVALUATION OF AI AND CDAI
The correlation between the subjective ratings of the three gastroenterologists from other institutions and the AI was quite satisfactory: 0.74; 077, and 0.87, respectively.
In the 20 healthy volunteers the AI ranged from 41 to 116 points (mean±SD: 86l1 ±18.4). Five (25%) of these volunteers had an AI > 100, which in patients with Crohn's disease would indicate slight activity. Values found for the CDAI ranged from -5 to 68 (mean ±SD: 27.0±20.6); according to Best et al.1 a CDAI <150 indicated quiescent Crohn's disease.
The relation between physician's rating and AI and CDAI, respectively, in the 64 patients with Crohn's disease is shown in Fig. 2 and 3 , respectively. A good correlation was found between physician's rating and AI (r=0.91). There was only a slight overlap in index values between successive classes of activity, with the exception of the classes 'no' and 'slight' activity. As Fig. 3 indicates, the correlation between physician's rating and CDAI was less pronounced was expected to show no significant increase or decrease. The AI was indeed found to have changed slightly (less than 20 points) in 12 of the 16 patients. In 1 1 of the 16 patients the physician's rating was the same on both occasions, and the AI was found also to have changed only slightly. In four patients the physican's rating at the follow-up was 1 point lower; in three of these four patients the Al was likewise substantially decreased. In one patient the inflammatory activity was rated 1 point higher, and the AI in this case showed a substantial increase.
The CDAI was substantially (more than 40 points) higher at the first outpatient follow-up than during the hospital period in eight of the 16 patients. Particularly in patients with a low CDAI in hospital, this increased considerably after discharge (even in patients in whom the physician's rating indicated decreased inflammatory activity after two weeks). This increase should probably be explained by an increase in subjective complaints after discharge from hospital. The CDAI is largely determined by subjective variables (general well being, abdominal pain).
The physician's subjective rating of the effect of therapeutic medication during one to six months on the inflammatory activity in 16 patients with Crohn's disease, and the corresponding activity indices AI and CDAI, are presented in Fig. 6 . This Figure shows that the change in AI generally corresponded well with the physician's rating of the therapeutic effect. For the CDAI this was much less clear-cut. group.bmj.com on June 21, 2017 -Published by http://gut.bmj.com/ Downloaded from Discussion Best et al. ' were the first to evolve a method of quantifying the inflammatory activity in Crohn's disease in a less arbitrary manner than was usually done in the past. The fact that this activity index (CDAI) is now being used in a number of prospective studies, demonstrates the urgent need for such an index. Nevertheless, the CDAI has a number of disadvantages. It was evolved with the cooperation of 18 physicians in 13 hospitals. At outpatient follow-up, these physicians formulated an overall evaluation of 'how the patient was doing'. At the same time, a large number of subjective and objective variables were registered. The number of patients thus studied totalled 112 (three to 20 patients from each centre). Multiple regression analysis was applied in an effort to determine which combination of variables correlated most closely with the subjective evaluation by the physician.
The publication of Best et al. ' does not indicate whether the physician based his rating on an overall subjective impression or in part also on data from the history, results of physical examination, or laboratory findings. The inter-rater agreement of the subjective ratings was not studied. In the development of the CDAI with the aid of multiple regression analysis, several variables were arbitrarily omitted (abdominal tenderness, serum albumin level) or added (body weight). The ultimate CDAI is made up of eight variables (stool consistency, abdominal pain, general well-being, extraintestinal symptoms of Crohn's disease, use of Lomotil or opiates against diarrhoea, abdominal mass, haematocrit, and body weight).
An important objection to the CDAI is that it is largely determined by subjective variables (abdominal pain, general well-being). The contribution of these variables to the sum of the standardised regression coefficients amounts to 39%. To register these subjective variables, the patient must be asked to keep a diary card updated for at least a week. In the development of the CDAI, the fact that the medication often given in Crohn's disease may influence the subjective complaints (euphorising effect of prednisone, side-effects of salicylazosulphapyridine) was disregarded. Subjective complaints such as general malaise and abdominal pain are generally no reliable indication of inflammatory activity. Not infrequently, they result from complications or residual effects of the disease such as fistulisation or stenosis. The same applies to the rate of defaecation and stool consistency (their contribution to the CDAI amounts to 19%). Patients with Crohn's disease who have undergone a bowel resection (specifically ileocaecal resection) not infrequently have a high defaecation rate and produce soft stools, even though there need be no question of any activity (or relapse) of Crohn's disease.
On the other hand, important objective parameters of inflammatory activity such as serum albumin level and ESR, have not been included in the CDAI. The validity of the CDAI is further reduced by the marked overlaps in CDAI score between the various activity classes established on the basis of subjective rating. The correlation coefficient between the physician's subjective rating and the CDAI calculated from the data supplied by Best et al.1 is only 0.70. In patients with Crohn's disease examined by us, the CDAI was found to change significantly without any change in the physician's rating of the disease activity (Fig. 5) ; also, the CDAI insufficiently reflected the effect of medication (Fig. 6) .
The AI proposed in this paper, developed by analogy to the regression analysis applied by Best et al. ' is made up almost entirely of objective variables (Table 4) , of which the serum albumin level contributes most to the AI. The latter is explained by the fact that, according to the three specialists who rated the inflammatory activity, the serum albumin level is a good standard of activity in Crohn's disease. This opinion is based on the results of previous studies5 which showed a markedly higher correlation between serum albumin level and protein loss via the intestinal wall than between total serum protein, y-globulin level, ESR, or haemoglobin concentration and protein loss via the intestinal wall. The authors hold that protein loss via the intestinal wall is the most reliable parameter to measure the inflammatory activity in the intestine. For practical reasons (relatively long time required, necessity of very careful collection of stools without admixture of urine, radiation load), however, this loss cannot be measured in all patients, and not repeatedly.
As the AI strongly depends on the serum albumin level this index will be affected by inter-laboratory differences in serum albumin determination. Correction for these differences as described above is necessary.
The variable 'sex' in the AI constitutes a correction on the contribution of the Quetelet index (the reference values of this index are lower in females than in males).23 The variable 'resection' is related to the variable 'stool consistency'. Patients with a history of resection often produce less well-formed stools, regardless of inflammatory activity.
The high correlation between physician's rating and AI (r=0.95) is explained by the fact that the rating was done by three specialists of the same department, and was based exclusively on the 18 variables used in regression analysis. However, there van Hees, van Elieren, van Lier, and van Tongeren was also a high correlation between the ratings of three gastroenterologists from other institutions and the AI (r-0-74, 0.77, and 0.87, respectively). In the 64 patients whose inflammatory activity was rated by one of us, a high correlation between this rating and the AI was likewise found (r=091), whereas the correlation with the CDAI was only 0-57. In this group of patients the rating was in part based also on other variables than those used in the development of the AI-for example, data from the history, results of physical examination, and, sometimes, results of radiological examination. The high correlation between the physician's activity score and the AI, and the relatively low correlation with the CDAI, suggest that the physician's rating was based more on the characteristics included in the AI than on those contained in the CDAI. This has to be taken into account in comparing the merits of the two indices on the basis of Figs. 2, 3, 5, and 6, which is in favour of the AI. After all, this comparison is always based on a rating which was more Al-than CDAI-oriented. Nevertheless, the correlation between Al and rating (r=0.91) was found to be considerably higher than that between the CDAI and the rating by the physicians involved in the construction of that index (r=070). Even the correlation between AI and the ratings of three gastroenterologists not involved in the development of our index was substantially higher (r=074, 077, and 087, respectively) than that between CDAI and the ratings of the physicians involved (r=070).
The results shown in Fig. 5 also argue in favour of the AI, in so far as the AI reflects less effect from discharge from hospital than the CDAl. Figure 4 shows marked differences between the classification of the inflammatory activity of Crohn's disease according to the Al and the CDAI, respectively. This can be explained by the fact that the AI is based mostly on objective, and the CDAI substantially on subjective variables.
In view of the high correlations found between the AI and the physician's activity score within subgroups of the group of 64 patients, the AI can be used for patients with Crohn's disease localised in the small intestine as well as in the colon, and also for patients with a history of (limited) bowel resection. The AI shows an adequate response to changes in activity after therapeutic medication (Fig. 6) .
Our findings would seem to warrant the conclusion that the AI is a reliable measure of inflammatory activity in patients with Crohn's disease, and is very suitable for evaluation of the effect of therapy in these patients.
patients with Crohn's disease. 
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